GLP-1 RAs Reduce Early-Onset Colorectal Cancer Risk in T2D
A large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age taking the antidiabetic medications.
Medscape Medical News
source https://www.medscape.com/viewarticle/glp-1-ras-reduce-early-onset-colorectal-cancer-risk-patients-2024a1000jpu?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/glp-1-ras-reduce-early-onset-colorectal-cancer-risk-patients-2024a1000jpu?src=rss
Comments
Post a Comment